The aim of icompanion is to give patients with multiple sclerosis and their treating neurologists more insight into the patient's disease course by providing an overview of the subclinical (visible on MRI), clinical and self-reported disease activity and comparing it with other patients. The data collected in icompanion will allow the training of prognostic models that are able to test medication virtually. In this way, the neurologist will be able to quickly find the most effective medication for each patient.
icompanion joined the mHealthBelgium community
16/06/2020